TENAX THERAPEUTICS, INC. (TENX) › Shares OutstandingTENAX THERAPEUTICS, INC. (TENX) — Shares OutstandingAnnual figures by period end, from SEC filings.2011-04-30: 23.39M2012-04-30: 1.47M2013-04-30: 1.93M2014-04-30: 27.86M2015-04-30: 28.12M2015-12-31: 28.12M2016-12-31: 1.41M2017-12-31: 1.41M2018-12-31: 3.79M2019-12-31: 6.74M2020-12-31: 12.62M2021-12-31: 1.26M2022-12-31: 28.6K2023-12-31: 298.3K2024-12-31: 3.42M2025-12-31: 9.31M9.31M2011-04-30Shares Outstanding (shares)2025-12-31Period endedShares OutstandingChange YoYSource filing2025-12-319.31M+172.3%2026-03-10Balance as of period end2024-12-313.42M+1046.9%2026-03-10Balance as of period end2023-12-31298.3K+941.2%2025-03-25Balance as of period end2022-12-3128.6K-97.7%2024-03-28Balance as of period end2021-12-311.26M-90.0%2023-03-31Balance as of period end2020-12-3112.62M+87.2%2022-03-29Balance as of period end2019-12-316.74M+77.8%2021-04-16Balance as of period end2018-12-313.79M+168.6%2020-03-30Balance as of period end2017-12-311.41M+0.4%2019-04-01Balance as of period end2016-12-311.41M-95.0%2018-04-02Balance as of period end2015-12-3128.12M—2017-03-16Balance as of period end2015-04-3028.12M+0.9%2015-07-14Balance as of period end2014-04-3027.86M+1343.4%2015-07-14Balance as of period end2013-04-301.93M+31.2%2014-07-29Balance as of period end2012-04-301.47M-93.7%2013-06-26Balance as of period end2011-04-3023.39M—2012-07-25Balance as of period endOther metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresDividends Per ShareWeighted Average Diluted SharesEPS (Basic)